PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical research study was to determine the safety and effectiveness of
an experimental drug called rilonacept in subjects with gout who are beginning allopurinol
treatment for gout. Subjects will participate in this study for approximately 22 weeks.
Rilonacept is being studied for use in preventing allopurinol-induced gout flares.